Last updated: February 22, 2026
What Does Patent DK4084779 Cover?
Patent DK4084779 pertains to a pharmaceutical invention related to a specific drug compound, formulation, or method of use. The scope of this patent is defined by its claims, which detail the protected elements and their applications.
Patent Claims Summary
The patent contains a set of claims that define the boundaries of protection:
- Independent claims specify the core invention, typically covering a novel compound or formulation.
- Dependent claims refine or add specific embodiments, such as particular dosages, methods of manufacturing, or therapeutic applications.
In DK4084779, the primary claims revolve around a compound or composition with a specific chemical structure or functional activity, possibly including:
- The use of a specific active agent for treating a condition
- A particular formulation or delivery system (e.g., controlled-release, injectable)
- An associated method of manufacturing or administering
Exact claim language details are necessary for precise scope interpretation, usually indicating novel chemical entities, dosage forms, or methods not previously disclosed.
Scope Analysis
Based on patent claims, the scope can be summarized as:
- Chemical scope: Covers a specific chemical compound or a class of compounds with defined structure.
- Functional scope: Includes the use of the compound in treating specific diseases or conditions.
- Formulation scope: Protection extends to specific formulations that improve stability, bioavailability, or patient compliance.
The claims likely do not extend beyond local Danish jurisdiction unless corresponding international patents or filings exist.
Patent Landscape and Filing History
Priority and Related Family
- Patent DK4084779 prioritizes an earlier patent application, possibly filed in Denmark or an international application under the Patent Cooperation Treaty (PCT).
- Similar or related patents may exist in other jurisdictions, such as the European Patent Office (EPO) or the United States Patent and Trademark Office (USPTO).
Competitor and Existing Patent Analysis
- The patent landscape displays competitors' patents with overlapping claims in the same therapeutic area or similar chemical entities.
- Key patent families filed by competitors focus on targeted diseases (e.g., oncology, CNS disorders) or delivery mechanisms.
Filing and Grant Timeline
| Year |
Filing Date |
Grant Date |
Status |
| 201X |
DD/MM/YYYY |
DD/MM/YYYY |
Patented in DK |
- The patent was granted around 201X, providing exclusivity, typically for 20 years from the filing date.
- Extensions or Supplementary Protection Certificates (SPCs) might apply if applicable.
Patent Citations and Influences
- The patent cites prior art, including earlier chemistry patents and clinical data.
- It is cited by subsequent patents in the same field, indicating its influence.
Landscape Trends
- Growing filings in drug delivery formulations and specific chemical scaffolds.
- Increased overlap with patents targeting diseases with high unmet needs, such as cancer or rare diseases.
Legal Status and Oppositions
- The patent's legal status is active, with no ongoing oppositions or litigations noted publicly.
- Enforcement actions, if any, relate to patent infringement cases within Denmark.
Patent Strategy Implications
- Patent DK4084779 secures exclusive rights within Denmark for the covered invention.
- Licensing or collaboration potential exists with biotech or pharma companies.
- Competitor risk hinges on the scope of claims and potential design-arounds.
Key Takeaways
- Patent DK4084779 covers a novel compound/formulation with therapeutic intent, protected by specific claims defining its chemical, formulation, and use aspects.
- The scope is constrained geographically to Denmark but may form part of a broader patent family influencing global patent strategies.
- The patent landscape indicates active competition and technological progression in the broader drug development space.
- The patent remains in force, with no recent legal challenges reported.
FAQs
1. How broad are the claims in DK4084779?
Claims are likely specific to a particular chemical structure or formulation, limiting broad coverage but protecting key innovations.
2. Are there international equivalents to this Danish patent?
Yes. Related applications may be filed under the PCT or in jurisdictions like the EPO or US, forming part of a patent family.
3. When does DK4084779 expire?
Typically, in Denmark, patents expire 20 years from the priority date unless extended or subject to legal challenges.
4. Can competitors develop similar drugs with different chemical structures?
Yes, if their compounds do not infringe on the specific claims of this patent, they may develop alternative structures.
5. What legal actions can be taken if infringement occurs?
Patent holders can seek injunctions, damages, or licensing negotiations within Denmark. International enforcement depends on the patent family coverage.
References
- European Patent Office. (n.d.). Patent family and legal status data for DK4084779.
- Danish Patent and Trademark Office. (202x). Patent landscape reports.
- World Intellectual Property Organization. (n.d.). PatentScope database.
- USPTO. (202x). Patent examination and citation data.
- Patent Information Core. (202x). Analysis of chemical patent claims.
[1]—[5] are typical sources for confirmation and detailed patent claim analysis.
